C
Christopher Bellamy
Researcher at University of Edinburgh
Publications - 108
Citations - 5782
Christopher Bellamy is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Liver transplantation & Kidney. The author has an hindex of 36, co-authored 105 publications receiving 5179 citations. Previous affiliations of Christopher Bellamy include Edinburgh Royal Infirmary & Western General Hospital.
Papers
More filters
Journal ArticleDOI
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque,Gwen Wilkie,Marie M. Jones,Craig D. Higgins,Gillian Urquhart,Phoebe Wingate,David J. Burns,Karen A. McAulay,Marc Turner,Christopher Bellamy,P. Amlot,Deirdre Kelly,Alastair MacGilchrist,Maher K. Gandhi,Anthony J. Swerdlow,Dorothy H. Crawford +15 more
TL;DR: The results show that allogeneic CTLs are a safe and rapid therapy for PTLD, bypassing the need to grow C TLs for individual patients, and the response rate in this poor prognosis patient group is encouraging.
Journal ArticleDOI
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.
Anthony J. Demetris,David H. Adams,Christopher Bellamy,Karin Blakolmer,Andrew D. Clouston,Amar P. Dhillon,John J. Fung,Annette S. H. Gouw,Bengt Gustafsson,Hironori Haga,David J. Harrison,John Hart,Stefan G. Hubscher,R. Jaffe,Urmila Khettry,Charles Lassman,Klaus J. Lewin,Olivia M. Martinez,Yuichi Nakazawa,Desley Neil,Orit Pappo,Maria Parizhskaya,Parmjeet Randhawa,Susanne Rasoul-Rockenschaub,Finn Reinholt,Michel Reynes,Marie E. Robert,Athanassios C. Tsamandas,Ian R. Wanless,Russell H. Wiesner,Annika Wernerson,Fritz Wrba,Judy Wyatt,Hirohiko Yamabe +33 more
Journal ArticleDOI
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
Anthony J. Demetris,Christopher Bellamy,Stefan G. Hubscher,Jacqueline G. O'Leary,Parmjeet Randhawa,Sandy Feng,Desley Neil,Robert B. Colvin,Geoffrey W. McCaughan,John J. Fung,A. Del Bello,Finn P. Reinholt,Hironori Haga,Oyedele Adeyi,A J Czaja,Thomas D. Schiano,Maria Isabel Fiel,Maxwell L. Smith,Mylène Sebagh,R Y Tanigawa,Funda Yilmaz,Graeme J.M. Alexander,L Baiocchi,M Balasubramanian,Ibrahim Batal,Atul K. Bhan,John C. Bucuvalas,Carlos Thadeu Schmidt Cerski,F Charlotte,M. E. de Vera,M ElMonayeri,Paulo Fontes,Emma E. Furth,Annette S. H. Gouw,Sara Hafezi-Bakhtiari,John Hart,E Honsova,Wesam Ismail,Tomoo Itoh,N C Jhala,Urmila Khettry,Goran B. Klintmalm,Stuart J. Knechtle,Takaaki Koshiba,Tomasz Kozlowski,Charles Lassman,Jan Lerut,Josh Levitsky,L Licini,R Liotta,George V. Mazariegos,Marta I. Minervini,Joseph Misdraji,Thalachallour Mohanakumar,Johan Mölne,Imad Nasser,James Neuberger,M O'Neil,O Pappo,L Petrovic,Phillip Ruiz,Ozgul Sagol,A Sanchez Fueyo,Eizaburo Sasatomi,Abraham Shaked,M. Shiller,T Shimizu,Banu Sis,Aurelio Sonzogni,Heather L. Stevenson,Swan N. Thung,Giuseppe Tisone,Athanassios C. Tsamandas,Annika Wernerson,Tong Wu,A. Zeevi,Yoh Zen +76 more
TL;DR: New recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization are included.
Journal ArticleDOI
Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm
Jayne L. Dennis,Torgeir R. Hvidsten,Ernst Wit,Jan Komorowski,Alexandra K. Bell,Ian Downie,Jacqueline Mooney,Caroline Verbeke,Christopher Bellamy,W. Nicol Keith,Karin A. Oien +10 more
TL;DR: In this paper, the authors proposed a classification scheme for patients with metastatic adenocarcinoma of unknown origin, which can enable better prediction on biopsy material of the primary site in patients with unknown origin.
Journal Article
Markers of adenocarcinoma characteristic of the site of origin : development
Jayne L. Dennis,Torgeir R. Hvidsten,Ernst Wit,Jan Komorowski,Alexandra K. Bell,Ian Downie,Jacqueline Mooney,Caroline Verbeke,Christopher Bellamy,W. Nicol Keith,Karin A. Oien +10 more
TL;DR: This classification scheme should enable better prediction on biopsy material of the primary site in patients with metastatic adenocarcinoma of unknown origin, leading to improved management and therapy.